David P. Meeker

2022

In 2022, David P. Meeker earned a total compensation of $3.3M as Chief Executive Officer at RHYTHM PHARMACEUTICALS, a 49% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$505,420
Option Awards$2,157,300
Salary$652,050
Other$10,988
Total$3,325,758

Meeker received $2.2M in option awards, accounting for 65% of the total pay in 2022.

Meeker also received $505.4K in non-equity incentive plan, $652.1K in salary and $11K in other compensation.

Rankings

In 2022, David P. Meeker's compensation ranked 1,087th out of 5,756 executives tracked by ExecPay. In other words, Meeker earned more than 81.1% of executives.

ClassificationRankingPercentile
All
1,087
out of 5,756
81st
Division
Manufacturing
514
out of 3,133
84th
Major group
Chemicals And Allied Products
185
out of 1,419
87th
Industry group
Drugs
166
out of 1,320
87th
Industry
Pharmaceutical Preparations
124
out of 966
87th

Pay ratio

David P. Meeker's Pay$3,325,758
Median Employee's Pay$286,392
Pay Ratio

12

to 1

In 2022, the annual total compensation of David P. Meeker was $3,325,758.

The annual total compensation of the median employee at RHYTHM PHARMACEUTICALS was $286,392.

The ratio of David P. Meeker's pay to the pay of median employee was therefore 12 to one.

Source: SEC filing on April 27, 2023.

Meeker's colleagues

We found four more compensation records of executives who worked with David P. Meeker at RHYTHM PHARMACEUTICALS in 2022.

2022

Hunter Smith

RHYTHM PHARMACEUTICALS

Chief Financial Officer

2022

Yann Mazabraud

RHYTHM PHARMACEUTICALS

Executive Vice President, Head of International

2022

Jennifer Chien

RHYTHM PHARMACEUTICALS

Executive Vice President, Head of North America

2022

Joseph Shulman

RHYTHM PHARMACEUTICALS

Chief Technical Officer

News

In-depth

You may also like